Archyde, vom 16. April 2020

"The industry’s initial serenity about the financial consequences of the novel lung disease has vanished. The corona crisis will cost insurers a lot, believes the consulting firm Meyerthole Siems Kohlruss (MSK)", heißt es auf Archyde.